Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers wit...

by Susanna Bianzano, Tim Heise, Arvid Jungnik, Cornelia Schepers, Corinna Schölch, Ulrike Gräfe-Mody
Published 2021-08-01

Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies

by Constance Stegbauer, Camilla Falivena, Ariadna Moreno, Anna Hentschel, Magda Rosenmöller, Tim Heise, Joachim Szecsenyi, Freimut Schliess
Published 2020-11-01

Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial.

by Stephan Martin, Christian Herder, Nanette C Schloot, Wolfgang Koenig, Tim Heise, Lutz Heinemann, Hubert Kolb, DIATOR Study Group
Published 2011-03-01

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

by Hubert Kolb, Kathrin Lückemeyer, Tim Heise, Christian Herder, Nanette C Schloot, Wolfgang Koenig, Lutz Heinemann, Stephan Martin, DIATOR Study Group
Published 2013-01-01

Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes.

by Othmar Moser, Max L Eckstein, Olivia McCarthy, Rachel Deere, Stephen C Bain, Hanne L Haahr, Eric Zijlstra, Tim Heise, Richard M Bracken
Published 2018-01-01

Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).

by Alexander Strom, Hubert Kolb, Stephan Martin, Christian Herder, Marie-Christine Simon, Wolfgang Koenig, Tim Heise, Lutz Heinemann, Michael Roden, Nanette C Schloot, DIATOR Study Group
Published 2012-01-01